The FDA has announced approval for onabotulinumtoxinA to treat urinary incontinence resulting from detrusor overactivity in patients with conditions such as spinal cord injury or multiple sclerosis. Medscape Medical News
The 27th Annual Scientific Meeting of the American Pain Society offered new information on improving pain management in the elderly. Medscape Neurology & Neurosurgery
In the large PERFORM trial, terutroban had no better efficacy and did not show any safety advantage over aspirin, still the gold standard. Medscape Medical News
A phase 2B trial suggests tenecteplase, a genetically engineered thrombolytic used to treat myocardial infarction, may be an alternative to alteplase in some patients with stroke. Medscape Medical News